Moaz Sial, | |
1015 S Hackett Rd, Waterloo, IA 50701-3500 | |
(319) 234-5990 | |
Not Available |
Full Name | Moaz Sial |
---|---|
Gender | Male |
Speciality | Gastroenterology |
Experience | 12 Years |
Location | 1015 S Hackett Rd, Waterloo, Iowa |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1891102364 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207RG0100X | Internal Medicine - Gastroenterology | MD-46760 (Iowa) | Primary |
Facility Name | Location | Facility Type |
---|---|---|
Allen Hospital | Waterloo, IA | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Cedar Valley Medical Specialists Pc | 1759291487 | 100 |
News Archive
A Swiss research team has found that using an animal's own brain cells (autologous transplant) to replace degenerated neurons in select brain areas of donor primates with simulated but asymptomatic Parkinson's disease and previously in a motor cortex lesion model, provides a degree of brain protection and may be useful in repairing brain lesions and restoring function.
A yearlong beach study led by a team of University of Miami researchers suggests that swimmers at sub-tropical beaches face an increased risk of illness. The multi-disciplinary team examined the risk of illness that beachgoers face when exposed to recreational marine water at sub-tropical beaches with no known source of pollution or contamination.
Pharmacyclics, Inc. today announced results from a Phase I study of its novel orally administered Bruton's tyrosine kinase (Btk) inhibitor, PCI-32765, in patients with relapsed or refractory B cell non-Hodgkin's lymphoma (NHL) including chronic lymphocytic leukemia (CLL) and Waldenstroms Macroglobulinemia (WM). These data are being presented at the American Society of Clinical Oncology (ASCO) Annual Meeting taking place this week in Chicago, IL.
The Maryland Proton Treatment Center chose "Survivor" as the theme for its grand opening in 2016, invoking the reality-TV show's tropical sets with its own Tiki torches, palm trees and thatched booths piled with pineapples and bananas.
Tolerx, Inc., a biopharmaceutical company developing novel therapies to treat autoimmune diseases and cancer by modulating T cell activity, presented results from preclinical studies with TRX518, an early-stage agent Tolerx is developing as a treatment for cancer. TRX518 is a monoclonal antibody to glucocorticoid-induced tumor necrosis factor receptor (GITR) and is designed to enhance the immune system's ability to attack tumors by activating and rendering T effector cells resistant to T regulatory cell suppression.
› Verified 5 days ago
Entity Name | Peoples Memorial Hospital |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1336281245 PECOS PAC ID: 9931010790 Enrollment ID: O20031118000161 |
News Archive
A Swiss research team has found that using an animal's own brain cells (autologous transplant) to replace degenerated neurons in select brain areas of donor primates with simulated but asymptomatic Parkinson's disease and previously in a motor cortex lesion model, provides a degree of brain protection and may be useful in repairing brain lesions and restoring function.
A yearlong beach study led by a team of University of Miami researchers suggests that swimmers at sub-tropical beaches face an increased risk of illness. The multi-disciplinary team examined the risk of illness that beachgoers face when exposed to recreational marine water at sub-tropical beaches with no known source of pollution or contamination.
Pharmacyclics, Inc. today announced results from a Phase I study of its novel orally administered Bruton's tyrosine kinase (Btk) inhibitor, PCI-32765, in patients with relapsed or refractory B cell non-Hodgkin's lymphoma (NHL) including chronic lymphocytic leukemia (CLL) and Waldenstroms Macroglobulinemia (WM). These data are being presented at the American Society of Clinical Oncology (ASCO) Annual Meeting taking place this week in Chicago, IL.
The Maryland Proton Treatment Center chose "Survivor" as the theme for its grand opening in 2016, invoking the reality-TV show's tropical sets with its own Tiki torches, palm trees and thatched booths piled with pineapples and bananas.
Tolerx, Inc., a biopharmaceutical company developing novel therapies to treat autoimmune diseases and cancer by modulating T cell activity, presented results from preclinical studies with TRX518, an early-stage agent Tolerx is developing as a treatment for cancer. TRX518 is a monoclonal antibody to glucocorticoid-induced tumor necrosis factor receptor (GITR) and is designed to enhance the immune system's ability to attack tumors by activating and rendering T effector cells resistant to T regulatory cell suppression.
› Verified 5 days ago
Entity Name | Cedar Valley Medical Specialists Pc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1497794242 PECOS PAC ID: 1759291487 Enrollment ID: O20031208000462 |
News Archive
A Swiss research team has found that using an animal's own brain cells (autologous transplant) to replace degenerated neurons in select brain areas of donor primates with simulated but asymptomatic Parkinson's disease and previously in a motor cortex lesion model, provides a degree of brain protection and may be useful in repairing brain lesions and restoring function.
A yearlong beach study led by a team of University of Miami researchers suggests that swimmers at sub-tropical beaches face an increased risk of illness. The multi-disciplinary team examined the risk of illness that beachgoers face when exposed to recreational marine water at sub-tropical beaches with no known source of pollution or contamination.
Pharmacyclics, Inc. today announced results from a Phase I study of its novel orally administered Bruton's tyrosine kinase (Btk) inhibitor, PCI-32765, in patients with relapsed or refractory B cell non-Hodgkin's lymphoma (NHL) including chronic lymphocytic leukemia (CLL) and Waldenstroms Macroglobulinemia (WM). These data are being presented at the American Society of Clinical Oncology (ASCO) Annual Meeting taking place this week in Chicago, IL.
The Maryland Proton Treatment Center chose "Survivor" as the theme for its grand opening in 2016, invoking the reality-TV show's tropical sets with its own Tiki torches, palm trees and thatched booths piled with pineapples and bananas.
Tolerx, Inc., a biopharmaceutical company developing novel therapies to treat autoimmune diseases and cancer by modulating T cell activity, presented results from preclinical studies with TRX518, an early-stage agent Tolerx is developing as a treatment for cancer. TRX518 is a monoclonal antibody to glucocorticoid-induced tumor necrosis factor receptor (GITR) and is designed to enhance the immune system's ability to attack tumors by activating and rendering T effector cells resistant to T regulatory cell suppression.
› Verified 5 days ago
Entity Name | Waverly Health Center |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1598959371 PECOS PAC ID: 8820996762 Enrollment ID: O20031230000129 |
News Archive
A Swiss research team has found that using an animal's own brain cells (autologous transplant) to replace degenerated neurons in select brain areas of donor primates with simulated but asymptomatic Parkinson's disease and previously in a motor cortex lesion model, provides a degree of brain protection and may be useful in repairing brain lesions and restoring function.
A yearlong beach study led by a team of University of Miami researchers suggests that swimmers at sub-tropical beaches face an increased risk of illness. The multi-disciplinary team examined the risk of illness that beachgoers face when exposed to recreational marine water at sub-tropical beaches with no known source of pollution or contamination.
Pharmacyclics, Inc. today announced results from a Phase I study of its novel orally administered Bruton's tyrosine kinase (Btk) inhibitor, PCI-32765, in patients with relapsed or refractory B cell non-Hodgkin's lymphoma (NHL) including chronic lymphocytic leukemia (CLL) and Waldenstroms Macroglobulinemia (WM). These data are being presented at the American Society of Clinical Oncology (ASCO) Annual Meeting taking place this week in Chicago, IL.
The Maryland Proton Treatment Center chose "Survivor" as the theme for its grand opening in 2016, invoking the reality-TV show's tropical sets with its own Tiki torches, palm trees and thatched booths piled with pineapples and bananas.
Tolerx, Inc., a biopharmaceutical company developing novel therapies to treat autoimmune diseases and cancer by modulating T cell activity, presented results from preclinical studies with TRX518, an early-stage agent Tolerx is developing as a treatment for cancer. TRX518 is a monoclonal antibody to glucocorticoid-induced tumor necrosis factor receptor (GITR) and is designed to enhance the immune system's ability to attack tumors by activating and rendering T effector cells resistant to T regulatory cell suppression.
› Verified 5 days ago
Mailing Address | Practice Location Address |
---|---|
Moaz Sial, Po Box 2758, Waterloo, IA 50704-2758 Ph: (319) 235-5390 | Moaz Sial, 1015 S Hackett Rd, Waterloo, IA 50701-3500 Ph: (319) 234-5990 |
News Archive
A Swiss research team has found that using an animal's own brain cells (autologous transplant) to replace degenerated neurons in select brain areas of donor primates with simulated but asymptomatic Parkinson's disease and previously in a motor cortex lesion model, provides a degree of brain protection and may be useful in repairing brain lesions and restoring function.
A yearlong beach study led by a team of University of Miami researchers suggests that swimmers at sub-tropical beaches face an increased risk of illness. The multi-disciplinary team examined the risk of illness that beachgoers face when exposed to recreational marine water at sub-tropical beaches with no known source of pollution or contamination.
Pharmacyclics, Inc. today announced results from a Phase I study of its novel orally administered Bruton's tyrosine kinase (Btk) inhibitor, PCI-32765, in patients with relapsed or refractory B cell non-Hodgkin's lymphoma (NHL) including chronic lymphocytic leukemia (CLL) and Waldenstroms Macroglobulinemia (WM). These data are being presented at the American Society of Clinical Oncology (ASCO) Annual Meeting taking place this week in Chicago, IL.
The Maryland Proton Treatment Center chose "Survivor" as the theme for its grand opening in 2016, invoking the reality-TV show's tropical sets with its own Tiki torches, palm trees and thatched booths piled with pineapples and bananas.
Tolerx, Inc., a biopharmaceutical company developing novel therapies to treat autoimmune diseases and cancer by modulating T cell activity, presented results from preclinical studies with TRX518, an early-stage agent Tolerx is developing as a treatment for cancer. TRX518 is a monoclonal antibody to glucocorticoid-induced tumor necrosis factor receptor (GITR) and is designed to enhance the immune system's ability to attack tumors by activating and rendering T effector cells resistant to T regulatory cell suppression.
› Verified 5 days ago
Paul Franke, M.D. Gastroenterology Medicare: Not Enrolled in Medicare Practice Location: 3421 W 9th St, Waterloo, IA 50702 Phone: 319-272-5655 Fax: 319-272-7313 | |
Dr. Kalyana Sundaram, MD Gastroenterology Medicare: Medicare Enrolled Practice Location: 419 East Donald Street, Waterloo, IA 50703 Phone: 319-236-1911 Fax: 319-287-5832 | |
Russell Adams, MD Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 146 W Dale St, Suite 201, Waterloo, IA 50703 Phone: 319-234-4431 Fax: 319-235-5004 | |
Joud Ghassoub Dib, M.D. Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 419 East Donald Street, Waterloo, IA 50703 Phone: 319-236-1911 Fax: 319-287-5832 | |
Dr. Pradeep Manjanbail Ramesh, MD Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 1825 Logan Ave, Waterloo, IA 50703 Phone: 319-235-3838 Fax: 319-235-5272 | |
Suresh Katapalli Reddy, MD Gastroenterology Medicare: Not Enrolled in Medicare Practice Location: 125 E Tower Park Dr, Waterloo, IA 50701 Phone: 319-234-5990 Fax: 319-234-5994 | |
Thomas R Spragg, MD Gastroenterology Medicare: Not Enrolled in Medicare Practice Location: 1717 W Ridgeway Ave, Waterloo, IA 50701 Phone: 319-833-5700 Fax: 319-833-5740 |